TakeNSE:TAKE -4.99%30 Net Margin % is 8.05% as of Mar. 2026. GuruFocus rates NSE:TAKE with a GF Score™ of 30/100 and a GF Value™ of ₹0.01 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Take ranks better than 93.39% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Take's Net Income for the
three
months ended in Mar. 2026 was ₹43.6 Mil. Take's Revenue for the
three
months ended in Mar. 2026 was ₹541.9 Mil. Therefore, Take's net margin for the quarter that ended in Mar. 2026 was 8.05%.
The historical rank and industry rank for Take's Net Margin % or its related term are showing as below:
NSE:TAKE'
s Net Margin % Range Over the Past 10 Years
Min: -3320.93 Med: -0.56 Max: 20.02
Current: 20.02
NSE:TAKE's Net Margin % is ranked better than 93.39% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 2.915
vs NSE:TAKE: 20.02
Take (NSE:TAKE) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Take Net Margin % Related Terms
Take Net Margin % Historical Data
* Premium members only.
The historical data trend for Take's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:TAKE vs VRTX, REGN, ALNY: Net Margin % Comparison
For the Health Information Services subindustry, Take's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Take Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Take's Net Margin % distribution charts can be found below:
* The bar in red indicates where Take's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Take (NSE:TAKE) has a Net Margin % of 8.05% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Take and its competitors. According to the industry distribution chart, Take ranks #44 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 6.6%.
Is Take's Net Margin % too high?
Take's current Net Margin % is 8.05%. The Healthcare Providers & Services industry median Net Margin % is 2.92. Take's value of 8.05% is 176.2% above this industry median. Based on the distribution chart, Take ranks #44 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Take has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Take's Net Margin % compare to VRTX and REGN?
According to the Healthcare Providers & Services industry distribution chart, Take ranks #44 out of 666 companies for Net Margin %. This places Take in the top 7% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.92. Take's value of 8.05% is 176.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.92, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Take's current Net Margin % of 8.05% is 176.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Take and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Take's current Net Margin % is 8.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Take stock overvalued right now?
Based on GuruFocus' analysis, Take (NSE:TAKE) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹0.01, compared to a current price of ₹22.83 — trading 228200% above its estimated fair value. The current Net Margin % is 8.05% and 176.2% above the Healthcare Providers & Services industry median of 2.92. Take's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Take (NSE:TAKE), the current Net Margin % is 8.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Take (NSE:TAKE) Overvalued in 2026?
Based on GuruFocus' analysis, Take stock appears to be overvalued.
The current stock price of ₹22.83 is trading 228200% above its estimated GF Value™ of ₹0.01.
GuruFocus considers Take to be Significantly Overvalued.
Key valuation signals for NSE:TAKE:
Net Margin %: 8.05%
GF Value™: ₹0.01 vs. price of ₹22.83 (228200% above fair value)
Industry Position: 176.2% above the Healthcare Providers & Services median (#44 of 666)
No single metric tells the full story. See the NSE:TAKE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Take Solutions Ltd is a technology solutions provider specializing in Life Sciences and Supply Chain Management services. The company offers integrated services including clinical research, generics support, regulatory affairs, pharmacovigilance, and data sciences. It supports pharmaceutical, biotech, and medical device companies to various countries with technology-backed solutions that enhance drug development and regulatory compliance. Revenue is driven by its broad portfolio of IT-enabled services focused on the life sciences industry and supply chain management, catering to a client base of innovators, generics manufacturers, and biotech firms.
30GF Score
Get the complete analysis for NSE:TAKE
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:TAKE has been successfully added to your 
